The role of p53 in human colitis-associated neoplasia has been studied by both immunohistochemistry and molecular techniques, and it has been reported that nuclear expression of, and the presence of mutations in, this gene can occur as early events, in contrast with non-colitic colorectal neoplasias (Cooper et al., 2000). This evidence concerns the gene TP53 and neoplasm.